Parkinsons Disease Companies in BioPortfolio's Corporate Database
Parkinsons Disease company data on BioPortfolio. Our corporate data records list over 50,000 company records. Here you can see the latest Parkinsons Disease companies that have been added to our BioPortfolio's life-science corporate directory.
Search For More Parkinsons Disease Companies
If you don't find the company you're looking for in the list below, you may wish to search our extensive database for further matches: Search for More Parkinsons Disease Companies.
More Information about Parkinsons Disease on BioPortfolio
We have published hundreds of Parkinsons Disease news stories on BioPortfolio along with dozens of Parkinsons Disease Clinical Trials. In addition to the corporate data, news and clinical trials, BioPortfolio also has a large collection of PubMed Articles about Parkinsons Disease for you to read.
Showing "parkinsons parkinson parkinsonism" Companies 1 to 25 of 111
Elan Corporation, plc is a neuroscience-based biotechnology company focused on discovering and developing advanced therapies in neurodegeneration and autoimmune diseases, and realizing the potential of its scientific discoveries to benefit patients and shareholders. The company has two business units: BioNeurology, focused on Alzheimerâs and Parkinson...
C2N Diagnostics, InterVivo Solutions, and inviCRO
C2N Diagnostics, LLC (www.c2ndiagnostics.com) formed in late 2007 by scientific co-founders Drs. David Holtzman and Randall Bateman of Washington University School of Medicine in St. Louis, the Washington University Office of Technology Management, and LifeTech Research, a Maryland-based technology research and commercialization firm (www.lifetechresearch....
Amarantus BioScience, Inc. is a development-stage biotechnology company founded in January 2008. The Company has a focus on developing certain biologics surrounding the intellectual property and proprietary technologies it owns to treat and/or diagnose Parkinsonâs disease, Traumatic Brain Injury, Ischemic Heart Disease and other human diseases. The Co...
Avid Radiopharmaceuticals, Inc.
Avid Radiopharmaceuticals is a leader in the development of molecular imaging products with the potential for earlier and more effective detection, diagnosis and monitoring of major chronic human diseases. Based in Philadelphia, PA, the companyâs lead program is a molecular imaging agent for amyloid plaque that could lead to earlier detection and bett...
Population Diagnostics, Inc. (PDx, www.populationdiagnostics.com) is applying its discoveries in human genetics to the development of DNA-based diagnostics and personalized medicine tests. PDxâs technology, which reveals the genetic causes of complex diseases such as autism, diabetes, Parkinsonâs, and Alzheimerâs, enables development of early...
NeurOp, Inc. is an Atlanta-based biopharmaceutical company developing new medicines for central nervous system disorders, including depression, neuropathic pain, ischemia (stroke), schizophrenia, and Parkinsonâs disease. Its compounds target the NMDA receptor found on neurons in a manner designed to enhance therapeutic benefit without the negative sid...
MicroTransponder (www.microtransponder.com) is developing a wireless neurostimulation system for the treatment of chronic pain and several other neurological indications. The minimally invasive device will provide relief from chronic pain without requiring an implanted battery or wires. The company is finalizing R&D on the device and accumulating data towa...
Amarantus Therapeutics, Inc. is a privately-held biotechnology company developing first-in-class diseaseâmodifying treatments that address the underlying cause of cell death, known as apoptosis, associated with a wide range of diseases, including but not limited to, neurodegenerative and cardiovascular. The Companyâs most advanced drug candidate, AMRS00...
Upsher-Smith Laboratories, Inc.
Upsher-Smith, founded in 1919, is an independent and privately-owned specialty pharmaceutical company headquartered in Maple Grove, Minnesota that focuses on product growth and innovation for branded, branded-generic and generic pharmaceuticals. Upsher-Smith has a particular focus on providing therapies to assist people suffering from central nervous syste...
Maas Biolab is a neuropharmaceutical company developing a treatment- the use of cyclosporins as neuro-protectants- for chronic neurodegenerative diseases including amyotrophic lateral sclerosis, Alzheimer's, Parkinson's and Huntington's. NeuroPharma AB, a Maas Biolab Swedish partner, is developing cyclosporin for treatment of the acute neurological indications of stroke, spinal trauma, and traumat...
Motac Neuroscience provides highly-specialised services for the pharmaceutical and biotechnology industries to support the discovery and development of therapeutics for neurological and psychiatric disorders. Motac personnel have extensive expertise in neurodegenerative conditions, particularly Parkinson's disease and other movement disorders.Motac also has an intellectual property portfolio prote...
Neurome, Inc. is a discovery stage biotechnology company that seeks therapeutic solutions to human neurodegenerative diseases. The company focuses its efforts on Alzheimer's disease, Parkinson's disease, Huntington's disease, and Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's disease) - usually fatal neurodegenerative disorders that are currently untreatable and share characteristics which mak...
NeuroNova is leading the development of therapeutic neurogenesis. Our drug development projects are aimed at stimulating processes in the brain that lead to the formation of new neurons. We believe therapeutic neurogenesis can revolutionize the treatment of several currently incurable neurodegenerative diseases, such as Parkinson’s disease and Alzheimer’s disease, as well as certain orphan dru...
Neurotech Pharmaceutical Inc. is a core biotechnology company in South Korea , established in 1998.Neurotech seeks to discover, develop, and commercialize major pharmaceutical products to cure brain related diseases, such as stroke, Parkinson ' s disease, Alzheimer ' s disease, spinal cord injury, and glaucoma. Our business strategy is to understand mechanisms of degenerative and regenerative neur...
Newron Pharmaceuticals SpA is a clinical stage biopharmaceutical company focused on the discovery and development of small molecule drugs for the treatment of central nervous system (CNS) diseases. Our clinical focus is on Parkinson's disease and pain. We were established in 1999 as a spin-off from Pharmacia & Upjohn and are headquartered in Bresso, near Milan, Italy. We are conducting Phase III c...
Novocell’s goal is to develop a renewable source of specialized cells that can be used to treat chronic cellular diseases. To achieve this goal, Novocell is uniquely positioned to exploit human stem cell engineered product opportunities using its proprietary cell encapsulation technology. Combined with Novocell's expertise in cell transplantation, these technologies will allow large numbers of p...
Here at Okanagan Clinical Trials we conduct medical studies on a variety of different conditions. Some of the illnesses we have studied to date include depression, anxiety, insomnia, diabetes, obesity, headaches, pain due to shingles, parkinson's disease and high cholesterol. Our goal is to provide a positive experience for the many patients who volunteer to participate in our trials.
Ophidia Products, Inc. is a privately held Texas corporation founded in 1991 for the purpose of discovering biologics for the treatment of human diseases and disorders. The founder and president, Dr. Binie V. Lipps, is a distinguished scientist, who has won several grants, attended and presented at many international meetings and published extensively in peer reviewed journals. -- The name - Ophid...
Oxford BioMedica (LSE: OXB) is a biopharmaceutical company specialising in the development of novel gene-based therapeutics with a focus on the areas of oncology and neurotherapy. The Company was established in 1995 as a spin out from Oxford University, and is listed on the London Stock Exchange.Oxford BioMedica’s products use genes as the mediators of a therapeutic effect and/or immune response...
Parkinsons & Movement Disorders Center
To provide expert, compassionate care for persons with movement disoders using a multidiciplinary approach and up to date treatment modalities. Appointments available in a timely fashion.
Penwest develops pharmaceutical products based on innovative proprietary drug delivery technologies. We are focusing our development efforts principally on products that address disorders of the nervous system. Our pipeline consists of product candidates in pain, epilepsy, depression, Parkinson’s disease and edema associated with congestive heart failure.
Originally formed as a medical device company, Power3 Medical Products, Inc. has since transitioned to an innovative holding company strategically positioned to acquire specialty healthcare and biotechnology assets. On May 18, 2004, Power3 purchased the assets and intellectual properties of ProteEx of The Woodlands, TX. The company was founded in 2000 by two seasoned medical biotechnology veterans...
Prana Biotechnology has developed a proprietary library of class-leading chemical compounds. This library is combined with a drug development program to explore novel therapeutics in multiple disease indications. The scientific focus of the company is upon neurological diseases, particularly Alzheimer‘s, Parkinson‘s and Huntington‘s diseases. The company listed on the Australian Stock Excha...
Prestwick Pharmaceuticals, Inc.
Prestwick Pharmaceuticals, Inc, is a product-based, specialty pharmaceutical company engaged in the development and marketing of small molecule drugs for chronic diseases of the central nervous system (CNS). Following our founding in 2002, we rapidly acquired rights to a promising portfolio of small molecule drugs, all with unique attributes and targeting chronic CNS conditions not adequately serv...
Company Description: ProteoTech Inc. is a world leader in research and development of new therapeutics derived from proteoglycan and amyloid technologies for the treatment of major human diseases. ProteoTech is developing human therapeutics for Alzheimer's, Parkinson's, prion diseases, type 2 diabetes, and systemic amyloidosis. In 1997, ProteoTech was granted a worldwide exclusive license from the...
